HCA Healthcare stock holds near a 52-week range low

HCA Healthcare stock (US40412C1018) closed at USD 427.71 on September 18, 2026, down 0.31 percent from the prior close of USD 429.04. The move came after a September 18, 2026 rating update from Leerink Partners that kept the stock at Outperform with a price target of USD 492, while Yahoo Finance showed a 52-week range of USD 353.99 to USD 556.52 and market cap of USD 92.6 billion.

Q2 still sets the tone

For investors, the key operating backdrop remains the second quarter of fiscal 2026. Yahoo Finance showed Q2 FY26 revenue of USD 20.23 billion, earnings of USD 1.7 billion and diluted EPS of USD 7.59, while the EPS estimate stood at USD 7.50.

That means EPS beat the estimate by USD 0.09, or about 1.2 percent. The profit margin for Q2 FY26 was 8.40 percent, and the trailing profit margin was 8.77 percent, which keeps margin discipline in view after the latest quarter.

Price still trails the high

The shares ended September 18, 2026 at USD 427.71, which is 23.1 percent below the 52-week high of USD 556.52 and 20.0 percent above the 52-week low of USD 353.99. Volume reached 5,444,100 shares on the session, while the average volume was 1,525,814 shares.

On a longer view, Yahoo Finance showed HCA up 7.90 percent year to date and up 6.64 percent over one year as of September 18, 2026. That leaves the stock below its 1-year best levels even after the recent gain.

October comes next

Yahoo Finance listed an estimated earnings date of October 23, 2026, and an ex-dividend date of September 16, 2026. The same source also showed trailing EPS of USD 29.81 and a forward dividend of USD 3.12, equal to a yield of 0.73 percent.

More news and analyses on HCA Healthcare stock